Everolimus Tablet
Product Images NDC 0054-0482

6 FDA label images from Hikma Pharmaceuticals Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Everolimus (NDC 0054-0482). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem-structure-everolimus-usp-05-18-2024.jpg (Chem Structure Everolimus Usp 05 18 2024)

Chem-structure-everolimus-usp-05-18-2024.jpg (Chem Structure Everolimus Usp 05 18 2024)
Chemical structure of Everolimus, showing its molecular framework with various functional groups including hydroxyls, methoxy groups, and several ring systems.*
FDA Label Image

Figure4.jpg (Figure4)

Figure4.jpg (Figure4)
A Kaplan-Meier survival curve comparing Everolimus (N=277) and placebo (N=139) over time in months. The y-axis shows probability percentage, while the x-axis shows time in months. Everolimus shows increased survival probability over placebo, with censoring times marked. Hazard ratio is 0.33 (95% CI 0.25-0.43). Median survival times are 4.9 months for Everolimus and 1.9 months for placebo.*
FDA Label Image

Bl-evero-tabs-2pt5mg-30s-c50000030-04-k01.jpg (Bl Evero Tabs 2pt5mg 30s C50000030 04 K01)

Bl-evero-tabs-2pt5mg-30s-c50000030-04-k01.jpg (Bl Evero Tabs 2pt5mg 30s C50000030 04 K01)
Label for Everolimus 2.5 mg oral tablets by Hikma Pharmaceuticals USA Inc. The label indicates a package of 30 tablets with usage instructions and storage conditions. The NDC code 0054-0480-13 is shown along with a barcode and the prescription-only designation.*
FDA Label Image

Bl-evero-tabs-5mg-30s-c50000029-04-k01.jpg (Bl Evero Tabs 5mg 30s C50000029 04 K01)

Bl-evero-tabs-5mg-30s-c50000029-04-k01.jpg (Bl Evero Tabs 5mg 30s C50000029 04 K01)
Everolimus 5 mg oral tablets packaging label showing a box containing 30 tablets. The label includes dosage strength (5 mg) and manufacturer information: Hikma Pharmaceuticals USA Inc. The packaging highlights storage instructions and prescription status (Rx only). A barcode and NDC number 0054-0481-13 are also visible.*
FDA Label Image

Bl-evero-tabs-7pt5mg-30s-c50000028-04-k01.jpg (Bl Evero Tabs 7pt5mg 30s C50000028 04 K01)

Bl-evero-tabs-7pt5mg-30s-c50000028-04-k01.jpg (Bl Evero Tabs 7pt5mg 30s C50000028 04 K01)
Label for Everolimus Tablets 7.5 mg by Hikma Pharmaceuticals USA Inc. The label shows the proprietary name, strength, oral tablet form, and states 30 tablets per package. Storage instructions and dosage usage directions refer to the package insert. The label includes barcode and NDC number 0054-0497-13.*
FDA Label Image

Bl-evero-tabs-10mg-30s-c50000027-04-k01.jpg (Bl Evero Tabs 10mg 30s C50000027 04 K01)

Bl-evero-tabs-10mg-30s-c50000027-04-k01.jpg (Bl Evero Tabs 10mg 30s C50000027 04 K01)
Label for Everolimus Tablets, 10 mg strength, oral tablets presented in a package of 30 tablets. The label includes storage instructions and usage warnings. Distributed by Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ. The label features a barcode, NDC 0054-0482-13, and highlights the prescription-only status with the Rx symbol.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.